Folic acid: Influence on the outcome of pregnancy

American Journal of Clinical Nutrition

Volumn 71, Issue 5 SUPPL., 2000, Pages

  Scholl, Theresa O ^a   Johnson, William G ^b  

^a UMDNJ School of Osteopathic Medicine   (United States)

^b NONE

Author keywords

Birth weight; Folic acid; Homocysteine; Placental abruption; Pregnancy; Pregnancy induced hypertension; Preterm delivery; Spontaneous abortion; Supplements; Vitamins

Indexed keywords

FOLIC ACID;

ADULT; CONFERENCE PAPER; EMBRYO DEVELOPMENT; FEMALE; FETUS DEVELOPMENT; FOLATE METABOLISM; FOLIC ACID DEFICIENCY; HUMAN; LOW BIRTH WEIGHT; PREGNANCY COMPLICATION; PREMATURE LABOR;

EID: 0034014432     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/71.5.1295s     Document Type: Conference Paper

References (75)

1. Wilcox AJ, Weinberg CR, O'Connor JF, et al. Incidence of early loss of pregnancy. N Engl J Med 1988;319:189-94.
2. Simpson JL. Fetal wastage. In: Gabbe SG, Niebyl JR, Simpson JL, eds. Obstetrics: normal & problem pregnancies. New York: Churchill Livingstone, 1996:717-42.
3. Ventura SJ, Martin JA, Curtin SC, Mathews TJ. Report of final natality statistics, 1995. Monthly vital statistics report. Vol 45(no. 11, suppl 2.) Hyattsville, MD: National Center for Health Statistics, 1997.
4. Rush RW, Kierse MJN, Howat P. Contribution of preterm delivery to perinatal mortality. Br Med J 1976;2:965-8.
5. Bernstein I, Gabbe SG. Intrauterine growth restriction. In: Gabbe SG, Niebyl JR, Simpson JL, eds. Obstetrics: normal and problem pregnancies. New York: Churchill Livingston, 1996:863-86.
6. Committee on Nutritional Status During Pregnancy and Lactation, Institute of Medicine. Nutrition during pregnancy. Washington, DC: National Academy Press, 1990.
7. Kramer MS. Determinants of low birth weight: methodological assessment and meta-analysis. Bull World Health Org 987;65:663-737.
8. Scholl TO, Hediger ML, Schall JI, Khoo CS, Fischer RL. Dietary and serum folate: their influence on the outcome of pregnancy. Am J Clin Nutr 1996;63:520-5.
9. Subar AF, Block G, James LD. Folate intake and food sources in the US population. Am J Clin Nutr 1989;50:508-16.
10. Block G, Abrams B. Vitamin and mineral status of women of childbearing potential. Ann N Y Acad Sci 1993;678:244-54.
11. Block G, Cox C, Madans J, Schreiber GB, Licitra L, Melia N. Vitamin supplement use, by demographic characteristics. Am J Epidemiol 1988;127:297-309.
12. Suitor CW, Gardner JD. Supplement use among a culturally diverse group of low-income pregnant women. J Am Diet Assoc 1990; 90:268-71.
13. Scholl TO, Hediger ML, Bendich A, Schall JI, Smith WK, Krueger PM. Use of multivitamin/mineral prenatal supplements: influence on the outcome of pregnancy. Am J Epidemiol 1997;146:134-41.
14. Yu SM, Keppel KG, Singh GK, Kessel W. Preconceptional and prenatal multivitamin-mineral supplement use in the 1988 National Maternal and Infant Health Survey. Am J Public Health 1996;86:240-2.
15. Cuskelly GJ, McNulty H, Scott JM. Effect of increasing dietary folate on red-cell folate: implications for prevention of neural tube defects. Lancet 1996;347:657-9.
16. Brown JE, Jacobs DR, Hartman TJ, et al. Predictors of red cell folate level in women attempting pregnancy. JAMA 1997;277:548-52.
17. Bendich A. Importance of vitamin status to pregnancy outcomes. In: Bendich A, Butterworth CE Jr, eds. Micronutrients in health and in disease prevention. New York: Marcel Dekker Inc, 1991: 235-62.
18. Wynn SW, Wynn AM, Doyle W, Crawford MA. The association of maternal social class with maternal diet and the dimensions of babies in a population of London women. Nutr Health 1994;9:303-15.
19. Bailey LB, Mahan CS, Dimperio D. Folacin and iron status in low-income pregnant adolescents and mature women. Am J Clin Nutr 1980;33:1997-2001.
20. Rosenblatt DS. Inherited disorders of folate transport and metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill, 1995:3111-28.
21. Mudd SH, Levy HL, Skovby F. Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill, 1995:1279-327.
22. Gibson RS. Principles of nutrition assessment. Oxford, United Kingdom: Oxford University Press, 1990.
23. Bakker RC, Brandjes DPM. Hyperhomocysteinaemin and associated disease. Pharm World Sci 1997;19:126-32.
24. van der Put NM, Eskes TK, Blom HJ. Is the common 677 C→T mutation in the methylenetetrahydrofolate reductase gene a risk factor for neural tube defects? A meta-analysis. QJM 1997;90: 111-5.
25. Motulsky AG. Nutritional ecogenetics: homocysteine-related arteriosclerotic vascular disease, neural tube defects, and folic acid. Am J Hum Genet 1996;58:17-20.
26. Jacques PF, Bostom AG, Williams RR, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996;93:7-9.
27. Mills JL, Scott JM, Kirke PN, et al. Homocysteine and neural tube defects. J Nutr 1996;126:756S-60S.
28. 12 are independent risk factors for neural tube defects. Q J Med 1993;86:703-8.
29. Molloy AM, Daly S, Mills JL, et al. Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations. Lancet 1997;349:1591-3.
30. James WP. Long-term fetal programming of body composition and longevity. Nutr Rev 1997;55:S31-43.
31. Posey DL, Khoury MJ, Mulinare J, Adams MJ Jr, Ou CY. Is mutated MTHFR a risk factor for neural tube defects? Lancet 1996;347:686-7 (letter).
32. Hibbard BM. The role of folic acid in pregnancy. J Obstet Gynaecol Br Commonw 1964;71:529-42.
33. Hibbard BM. Folates and the fetus. S Afr Med J 1975;49:1223-6.
34. Byrne J, Warburton D. Neural tube defects in spontaneous abortions. Am J Med Genet 1986;25:327-33.
35. Thenen SW. Gestational and neonatal folate deficiency in rats. Nutr Res 1991;11:105-16.
36. van der Put NMJ, Steeger-Theunissen RPM, Frosst P, et al. Mutated methylenetetrahydrafolate reductase gene is a genetics risk factor for spina bifida. Lancet 1995;346:1070-1.
37. Steegers-Theunissen RPM, Bous GHJ, Trijbels FJM, et al. Maternal hyperhomocysteinemia: a risk factor for neural tube defects? Metabolism 1994;43:1475-80.
38. Mudd SH, Skovby F, Levy HK, et al. The natural history of homocystinuria due to cystathione-beta-synthase-deficiency. Am J Hum Genet 1985;37:1-31.
39. Pietrzik K, Prinz R, Reusch K, Bung P, Mallmann P, Chronides A. Folate status and pregnancy outcome. Ann N Y Acad Sci 1992; 669:371-3.
40. Neiger R, Wise C, Contag SA, Tumber MB, Canick JA. First trimester bleeding and pregnancy outcome in gravidas with normal and low folate levels. Am J Perinatol 1993;10:460-2.
41. Neela J, Raman L. The relationship between maternal nutritional status and spontaneous abortion. Natl Med J India 1997;10:15-6.
42. Sutterlin M, Bussen S, Ruppert D, Steck T. Serum levels of folate and cobalamin in women with recurrent spontaneous abortion. Hum Reprod 1997;12:2292-6.
43. Wouters MGAJ, Boers GHJ, Blom HJ, et al. Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss. Fertil Steril 1993;60:820-5.
44. Steegers-Theunissen RPM, Boers GHJ, Blom HJ, Trijbels FJM, Eskes TKAB. Hyperhomocysteinemia and recurrent spontaneous abortion or abruptio placentae. Lancet 1992;339:1122-3.
45. Quere I, Bellet H, Hoffet M, Janbon C, Mares P, Gris J-C. A woman with five consecutive fetal deaths: case report and retrospective analysis of hyperhomocysteinemia prevalence in 100 consecutive women with recurrent miscarriages. Fertil Steril 1998;69:152-4.
46. Hook EB, Czeizel AE. Can terathanasia explain the protective effect of folic-acid supplementation on birth defects? Lancet 1997; 350:513-5.
47. Sohda S, Arinami T, Hamada H, Yamada N, Hamaguchi H, Kubo T. Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia. J Med Genet 1997;34:525-6.
48. de Vries JIP, Huijgens PC, Blomberg BME, Dekker GA, Jakobs C, van Geijn HP. Hyperhomocystenemia and protein S deficiency. Br J Obstet Gynaecol 1997;104:1248-54.
49. Goddijn-Wessel TAW, Wouters MGAJ, Molen EFVD, et al. Hyperhomocysteinemia: a risk factor for placental abruption or infarction. Eur J Obstet Gynecol Reprod Biol 1996;66:23-9.
50. Dekker GA, de Vries JIP, Doelitzsch PM, et al. Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol 1995;173:1042-8.
51. Rajkovic A, Catalano PM, Malinow MR. Elevated homocyst(e)ine levels with preeclampsia. Obstet Gynecol 1997;90:168-71.
52. Lewis CA, Pancharuniti N, Sauberlich HE. Plasma folate adequacy as determined by homocysteine level. Ann N Y Acad Sci 1992; 669:360-2.
53. 6 supplementation on women with hyperhomocysteinemia and a history of preeclampsia or fetal growth restriction. Am J Obstet Gynecol 1998;79:135-9.
54. Tamura T, Goldenberg RL, Johnston KE, Cliver SP, Hoffman HJ. Serum concentrations of zinc, folate, vitamins A and E, and proteins, and their relationships to pregnancy outcome. Acta Obstet Gynecol Scand 1997;165:63-70.
55. Goldenberg RL, Tamura T, Cliver SP, Cutter GR, Hoffman HJ, Copper RL. Serum folate and fetal growth retardation: a matter of com-pliance? Obstet Gynecol 1992;79:719-22.
56. Tamura T, Goldenberg RL, Freeberg LE, Cliver SP, Cutter GR, Hoffman HJ. Maternal serum folate and zinc concentrations and their relationships to pregnancy outcome. Am J Clin Nutr 1992;56:365-70.
57. Neggers YH, Goldenberg RL, Tamura T, Cliver SP, Hoffman HJ. The relationship between maternal dietary intake and infant birthweight. Acta Obstet Gynecol Scand 1997;165:71-5.
58. Frelut ML, de Courcy GP, Christides JP, Blot P, Navarro J. Relationship between maternal folate status and foetal hypotrophy in a population with a good socio-economical level. Int J Vitam Nutr Res 1995;65:267-71.
59. Ek J. Plasma and red cell folate in mothers and infants in normal pregnancies. Acta Obstet Gynecol Scand 1982;61:17-20.
60. Malinow MR, Rajkovic A, Duell PB, Hess DL, Upson BM. The relationship between maternal and neonatal umbilical cord plasma homocyst(e)ine suggests a potential role for maternal homocyst(e)ine in fetal metabolism. Am J Obstet Gynecol 1998;178:228-33.
61. Burke G, Robinson K, Refsum H, Stuart B, Graham I. Intrauterine growth retardation, perinatal death, and maternal homocysteine levels. N Engl J Med 1992;326:69-70.
62. 12 levels in normal pregnancy, and their influence on birth-weight and the duration of pregnancy. Med J Aust 1968;1:338-42.
63. Tchernia G, Blot I, Rey A, Kaltwasser JP, Zittoun J, Papiernik E. Maternal folate status, birthweight and gestational age. Dev Pharmacol Ther 1982;4:58-65.
64. Rondo PHC, Abbott R, Rodrigues LC, Tomkins AM. Vitamin A, folate, and iron concentrations in cord and maternal blood of intrauterine growth retarded and appropriate birth weight babies. Eur J Clin Nutr 1995;49:391-9.
65. Martin JD, Davis RE, Stenhouse N. Serum folate and vitamin B12 levels in pregnancy with particular reference to uterine bleeding and bacteriuria. J Obstet Gynaecol Br Commw 1967;74:697-701.
66. Fleming AF, Martin JD, Hahnel JR, Westlake AJ. Effects of iron and folic acid antenatal supplements on maternal haemutology and fetal wellbeing. Med J Aust 1974;2:429-36.
67. Fletcher J, Gurr A, Fellingham FR, Prankerd TAJ, Brant HA, Menzies DN. The value of folic acid supplements in pregnancy. J Obstet Gynaecol Br Commw 1971;78:781-5.
68. Giles PFH, Harcourt AG, Whiteside MG. The effect of prescribing folic acid during pregnancy on birth-weight and duration of pregnancy. Med J Aust 1971;2:17-21.
69. Baumslag N, Edelstein T, Metz J. Reduction of incidence of prematurity by folic acid supplementation in pregnancy. Br Med J 1970; 1:16-7.
70. Iyengar L, Rajalakshmi K. Effect of folic acid supplement on birth weights of infants. Am J Obstet Gynecol 1975;122:332-6.
71. Rolschau J, Date J, Kristoffersen K. Folic acid supplement and intrauterine growth. Acta Obstet Gynecol Scand 1979;58:343-4.
72. Blot I, Papiernik E, Kaltwasser JP, Werner E, Tchernia G. Influence of routine administration of folic acid and iron during pregnancy. Gynecol Obstet Invest 1981;12:294-304.
73. Czeizel AE, Dudas I, Metneki J. Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Arch Gynecol Obstet 1994;255:131-9.
74. Czeizel AE, Metneki J, Dudas I. The higher rate of multiple births after periconceptional mutlivitamin supplementation: an analysis of causes. Acta Genet Med Gemellol (Roma) 1994;43:175-84.
75. Czeizel A. Controlled studies of multivitamin supplementation on pregnancy outcome. Ann N Y Acad Sci 1993;678:266-75.